Guys.,
I'm exclusively looking to that report from FDA. I cant judge analyze or make assessment if the product will or will not.
I cut and paste areas that looks like they really diodnt found prove of efficacy.
But for sure plenty of experts here with qualification to judge analyze and consider better than me.
CATO
Note; The report I mention and copied and pasted was placed by another person here in the MSB tread under the name
"FDA briefing document Oncologic drugs advisory committee(ODAC)_ meeting
Session on Product Characterization (AM Session)
Ausgust 13,2020
BLA 125706
Remestemcel-L
Aplicant: Mesoblast,INc
MSB Trading - Aug 2020 on, page-579
-
- There are more pages in this discussion • 1,806 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8683 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 32999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |